Hereditary Hemorrhagic Telangiectasia (HHT) Center
Health Resources and Services Administration · Opportunity number HRSA-26-092
Details summarized from the official notice as of Jun 28, 2026. Always confirm eligibility, deadlines and requirements in the official notice before applying.
Independent platform. Not affiliated with or endorsed by any government agency. Data from public federal sources.
Key facts
| Opportunity number | HRSA-26-092 |
|---|---|
| Agency | Health Resources and Services Administration Department of Health and Human Services |
| Assistance listing (ALN, formerly CFDA) | 93.110 |
| Posted | Jun 8, 2026 |
| Deadline | Jul 10, 2026 |
| Award ceiling | $2,900,000 |
| Expected number of awards | 1 |
| Estimated total program funding | $2,900,000 |
| Cost sharing or matching required | No |
| Funding type | Cooperative agreement |
| Category | Health |
| Last updated here | Jun 28, 2026 |
Summary from the notice
Who can apply
The official notice lists these applicant types as eligible:
- State governments
- Unrestricted (open to any type of entity, check the notice)
Eligibility details from the notice
"Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
Registrations you will likely need
Most applications submitted through Grants.gov need the following. Registration can take several weeks, so start early. The notice lists the exact requirements.
- SAM.gov registration for your organization, which also gives you a Unique Entity ID (UEI). Registration is free.
- A Login.gov account, which Grants.gov uses for sign-in.
- A Grants.gov applicant registration linked to your organization's UEI.
Related open opportunities
Fiscal Year (FY) 2027 Service Area Competition (SAC)
Health Resources and Services Administration · HRSA-27-005
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-077
Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats
Centers for Disease Control-GHC · CDC-RFA-JG-26-0178
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health · PAR-25-155
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
National Institutes of Health · RFA-DE-27-001